J. Cai

发表

Identification and Functional Assessment of a New CYP2C9 Allelic Variant CYP2C9*59

D. Dai, G. Hu, Chuan-bao Li, 2015, Drug Metabolism and Disposition.

Microsoft Word-2957313-file00.docx

D. Dai, G. Hu, Chuan-bao Li, 2015 .

CYP2D6 gene polymorphism and apatinib affect the metabolic profile of fluvoxamine

Bin Wu, Jianchang Qian, G. Hu, 2022, Frontiers in Pharmacology.

Effects of CYP2C19 variants on the metabolism of tapentadol in vitro

G. Hu, R. Xu, Ping Fang, 2022, Iranian journal of basic medical sciences.

Identification and drug metabolic characterization of four new CYP2C9 variants CYP2C9*72-*75 in the Chinese Han population

Jie Yang, D. Dai, Quan Zhou, 2022, Frontiers in Pharmacology.

Effects of Simvastatin on the Metabolism of Vonoprazan in Rats Both in vitro and in vivo

Ji-hua Shi, D. Dai, Shuang-hu Wang, 2022, Drug design, development and therapy.

Evaluation of commonly used cardiovascular drugs in inhibiting vonoprazan metabolism in vitro and in vivo

Shuanghu Wang, D. Dai, Peiwu Geng, 2022, Frontiers in Pharmacology.

Assessments of CYP‑inhibition‑based drug–drug interaction between vonoprazan and poziotinib in vitro and in vivo

D. Dai, Shuang-hu Wang, P. Geng, 2023, Pharmaceutical biology.

The effect of CYP3A4 genetic polymorphism and drug interaction on the metabolism of istradefylline.

Jianchang Qian, G. Hu, J. Cai, 2022, Chemico-biological interactions.

In vitro assessment of 39 CYP2C9 variants found in the Chinese population on the metabolism of the model substrate fluoxetine and a summary of their effects on other substrates

H. Huang, D. Dai, Y. Ji, 2015, Journal of clinical pharmacy and therapeutics.

Clinical significance of the series of CYP2C9*non3 variants, an unignorable predictor of warfarin sensitivity in Chinese population

D. Dai, Jiefu Yang, Xinlong Zhao, 2022, Frontiers in Cardiovascular Medicine.

Effects of 22 Novel CYP2D6 Variants Found in the Chinese Population on the Bufuralol and Dextromethorphan Metabolisms In Vitro

D. Dai, G. Hu, Shuang-hu Wang, 2016, Basic & clinical pharmacology & toxicology.

Identification and in vitro functional assessment of 10 CYP2C9 variants found in Chinese Han subjects

Lili Zou, D. Dai, Jiefu Yang, 2023, Frontiers in Endocrinology.

Characterization of 15 CYP2J2 variants identified in the Chinese Han population on the metabolism of ebastine and terfenadine in vitro

D. Dai, Shuang-hu Wang, P. Geng, 2023, Frontiers in Pharmacology.

Polymorphic mutations in the polb gene promoter and their impact on transcriptional activity

Hui Li, Bin Hu, Shuanghu Wang, 2022, Thoracic cancer.

Effects of Cytochrome P450 2C9 Polymorphism on Bosentan Metabolism

Xianqin Wang, Jianping Cai, Mengchun Chen, 2014 .

Study on genotype and phenotype of novel CYP2D6 variants using pharmacokinetic and pharmacodynamic models with metoprolol as a substrate drug.

G. Hu, J. Cai, Jianchang Qian, 2024, The pharmacogenomics journal.

CYP3A4 and CYP2C19 genetic polymorphisms and myricetin interaction on tofacitinib metabolism.

R. Xu, J. Cai, Ya-nan Liu, 2024, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

The variability in CYP3A4 activity determines the metabolic kinetic characteristics of ketamine

G. Hu, Xiang Zheng, J. Cai, 2023, Toxicology.

Genetic variations of CYP3A4 on the metabolism of itraconazole in vitro

G. Hu, R. Xu, J. Cai, 2023, Food and Chemical Toxicology.

effects of 22 novel CYP2D6 variants found in chinese population on the metabolism of dapoxetine

G. Hu, R. Xu, J. Cai, 2016 .

Identification and Functional Assessment of Eight CYP3A4 Allelic Variants *39–*46 Detected in the Chinese Han Population

D. Dai, Shuang-hu Wang, P. Geng, 2024, Drug Metabolism and Disposition.